You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR CARBAMAZEPINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Carbamazepine

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000191 ↗	Carbamazepine Treatment for Cocaine Dependence - 5	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1991-01-01	The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000191 ↗	Carbamazepine Treatment for Cocaine Dependence - 5	Completed	University of Pennsylvania	Phase 2	1991-01-01	The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000217 ↗	Pharmacotherapy and Intensive Treatment of Drug Abuse - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1990-09-01	The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 ↗	Pharmacotherapy and Intensive Treatment of Drug Abuse - 1	Completed	US Department of Veterans Affairs	Phase 2	1990-09-01	The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Carbamazepine

Condition Name

Chart
Table

Condition Name for Carbamazepine
Intervention	Trials
Epilepsy	35
Bipolar Disorder	17
Healthy	12
Seizures	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Carbamazepine
Intervention	Trials
Epilepsy	49
Bipolar Disorder	22
Seizures	17
Disease	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Carbamazepine

Trials by Country

Map
Table

Trials by Country for Carbamazepine
Location	Trials
United States	168
Italy	24
Germany	21
Australia	16
United Kingdom	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Carbamazepine
Location	Trials
Maryland	14
New York	12
Texas	10
Kansas	10
North Carolina	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Carbamazepine

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Carbamazepine
Clinical Trial Phase	Trials
Phase 4	59
Phase 3	35
Phase 2/Phase 3	6
[disabled in preview]	30
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Carbamazepine
Clinical Trial Phase	Trials
Completed	117
Recruiting	18
Unknown status	17
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Carbamazepine

Sponsor Name

Chart
Table

Sponsor Name for Carbamazepine
Sponsor	Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	10
GlaxoSmithKline	7
UCB Pharma	7
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Carbamazepine
Sponsor	Trials
Other	176
Industry	107
NIH	21
[disabled in preview]	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.